Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 02-Sep 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 109818801000001113 | Aclidinium bromide 375micrograms/dose dry powder inhaler (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 109818901000001119 | Aclidinium bromide 375micrograms/dose dry powder inhaler | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Aclidinium bromide 375micrograms/dose dry powder inhaler | Is a | Virtual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
| Aclidinium bromide 375micrograms/dose dry powder inhaler | Is a | Aclidinium bromide | false | Inferred relationship | Existential restriction modifier | ||
| Aclidinium bromide 375micrograms/dose dry powder inhaler | Has active ingredient | Substance with muscarinic receptor antagonist mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
| Aclidinium bromide 375micrograms/dose dry powder inhaler | Is a | Aclidinium bromide | false | Inferred relationship | Existential restriction modifier | ||
| Aclidinium bromide 375micrograms/dose dry powder inhaler | Has active ingredient | Substance with muscarinic receptor antagonist mechanism of action | false | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR